The Journey of a Cancer-Fighting Stem Cell Therapy
Frontiers in Medicine 2022 gathered Stanford Medicine’s scientific and philanthropic communities in the historic Frost Amphitheater to explore a future of medicine that is both innovative and human-centered. A future that harnesses AI and big data to transform how we deliver care. A future where knowledge of human biology at a cellular, molecular, and genomic […]
Emulating the heart – Developing blood stem cells to treat cancer
Making stem cells from a patient’s adult cells – rather than human embryos – is one of the holy grails in modern medicine treatments. New research brings us two steps closer. *** All content on NationalStemCellTherapy.com is for informational purposes only. All medical questions and concerns should always be consulted with your licensed healthcare provider.
Global Mesenchymal Stem Cells (MSC) Market to Reach $6.5 Billion by 2027
New York, Oct. 19, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Mesenchymal Stem Cells (MSC) Industry” – https://www.reportlinker.com/p05961465/?utm_source=GNWOnline interactive peer-to-peer collaborative bespoke updatesAccess to our digital archives and MarketGlass Research PlatformComplimentary updates for one year Global Mesenchymal Stem Cells (MSC) Market to Reach $6.5 Billion by 2027 Amid the COVID-19 crisis, […]
How Do Epithelial Stem Cells Enable Renewal and Regeneration of Organs in the Adult? – Ophir Klein
How do epithelial stem cells enable renewal and regeneration of organs in adults? Ophir Klein, M.D., Ph.D., explains his research in stem cell-fueled tooth renewal and intestinal stem cells. Video Transcript: [MUSIC] I was going to talk today about a few different areas of the lab which revolve around this theme of how epithelial stem […]
How Stem Cells Can Treat Avascular Necrosis – Yale Medicine Explains
Dr. Wiznia explains what avascular necrosis is and how stem cells can treat this condition. Video Transcript: Stem cells are really important because they give us the ability to regenerate. We have cells in our bone marrow that are stem cells that then can become new blood vessels, new muscle, new bone. Orthopedics is very […]
BREAKTHROUGH TECHNOLOGY FOR IPS-DERIVED CELL THERAPIES TURNED INTO GMP PLATFORM BY TREEFROG THERAPEUTICS & INVETECH
BORDEAUX, France, Oct. 11, 2022 /PRNewswire/ — TreeFrog Therapeutics, a biotechnology company developing stem cell-derived therapies in regenerative medicine and immuno-oncology based on the biomimetic C-Stem™ technology platform, and Invetech, a global leader in the development and production of automated manufacturing solutions for cell and advanced therapies, today announced the delivery of a GMP-grade cell encapsulation device using the C-Stem™ technology. […]
Orchard Announces Multiple Presentations at 2022 ESGCT Annual Congress Showing the Potential of HSC Gene Therapy in Several Therapeutic Areas
BOSTON and LONDON, Oct. 10, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced multiple presentations at the 29th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT), taking place October 11-14, 2022, in Edinburgh. Clinical and pre-clinical data from across the company’s hematopoietic stem cell […]
ANDREWS MEDICINE AND CELLTEX THERAPEUTICS CORPORATION JOIN FORCES TO BRING CUTTING EDGE TECHNOLOGIES TO ATHLETIC INJURIES
HOUSTON, Oct. 4, 2022 /PRNewswire/ — James R. “Jim” Andrews, MD, Chairman and CEO of Andrews Medicine of Pensacola, Florida, and David G. Eller, Chairman and CEO of Celltex Therapeutics Corporation of Houston, Texas, announced today that together they will form a new biotechnology company to bridge the divide between stem cell research and the […]
Bone Marrow Transplant and Cell Therapies Unit at Tampa General Hospital Brings More Treatment Options to Cancer Patients
TAMPA, Fla., Oct. 3, 2022 /PRNewswire/ — As part of its commitment to world-class, innovative cancer care for the Tampa Bay region and beyond, Tampa General Hospital (TGH) Cancer Institute has established an adult Bone Marrow Transplant (BMT) and Cell Therapies unit that focuses on treating patients with aggressive blood cancers such as leukemias, lymphomas, multiple […]
Kadimastem Receives Approval of Patent Registration for Its Cell Selection and Enrichment Technology Used to Develop Its IsletRx Treatment for Diabetes in a Third Territory
NESS ZIONA, Israel, Sept. 28, 2022 /PRNewswire/ — Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing treatments for ALS and diabetes, has been granted its third patent approval for the company’s innovative cell selection and enrichment technology and its use in the production of IsletRx, the company’s treatment and potential cure for diabetes. […]